+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Wound Management Devices Market by Product, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2019-2026

  • ID: 5125518
  • Report
  • May 2020
  • Region: Global
  • 240 Pages
  • Allied Analytics LLP

FEATURED COMPANIES

  • 3M Company
  • Baxter International Inc.
  • Coloplast A/S
  • ConvaTec Inc.
  • Derma Sciences Inc.
  • Hollister Inc.
The global wound management devices market was valued at $13,396.8 million in 2018 and is projected to reach $18,818.4 million by 2026, registering a CAGR of 4.3% from 2019 to 2026. Wounds are one of the most common afflictions that affect billions of people worldwide. Wounds can be classified into acute and chronic based on the severity. Acute wounds are often recovered by natural healing process whereas chronic wounds are hard-to-heal due to complications from cardiovascular diseases (CVD), obesity, diabetes, and other lifestyle diseases. Thus, addressing these wounds require efficient and cost-effective wound management devices and practices, thereby, increasing the need for better wound healing products.



As per data published by the U.S. National Institute of Health, in 2017, wounds or chronic wounds affect approximately 6.5 million of the U.S. population and the number is likely to increase in the coming years. In addition, major pharmaceutical companies are introducing advanced wound care management devices for faster recovery of patients from acute and chronic wounds. For instance, in 2017, Smith & Nephew launched a handheld imaging device “MolecuLight i:X” in Europe that is specifically used in measuring wound surface area and detect harmful bacteria within it.

Factors such as increasing geriatric population across the globe, need for fast acting wound closure devices for prevention of blood loss during surgeries, and a rise in number of people suffering from chronic wounds and ulcers due to various diseases such as diabetes and CVDs primarily drives the market growth. In addition, technological advancements in wound healing procedures adopted by hospitals and clinics are further expected to boost the market growth. However, higher cost of treatments involved in wound management techniques is anticipated to restrain the market globally. Moreover, a lack of proper reimbursement policies in developing countries also hamper the growth of the wound management devices market. However, introduction of novel therapies for wound healing and growing number of therapy approvals such as negative pressure wound therapies and extracorporeal shock wave therapies, create newer opportunities for the growth of the market.

The wound management devices market is segmented on the basis of product, application, end user and region. Based on the product, the market is classified into therapy devices, wound closure devices and others. Based on the application, the wound management devices market is divided into burns, diabetic foot ulcers, pressure ulcers, surgical wounds and others. Based on end user, the market is segmented into hospitals, clinics, home care settings and others. Region wise, the market is further analysed across North America, Europe, Asia-Pacific and LAMEA.

Prominent players in the market have adopted various strategies such as developing advanced wound care therapies and product launch for maintaining their share in the wound management devices market thereby addressing the evolving healthcare needs among patients and healthcare providers. Some of the key players of the market include Baxter International Inc., Coloplast A/S, ConvaTec Inc., Derma Sciences Inc., Hollister Inc., Johnson & Johnson, 3M Company, Medtronic Plc., Mölnlycke Health Care, and Smith & Nephew.

KEY BENEFITS FOR STAKEHOLDERS
  • The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
  • Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS

BY Product
  • Therapy Devices
  • Wound closure Devices
  • Others

BY Application
  • Burns
  • Diabetic Foot Ulcers
  • Pressure ulcers
  • Surgical wounds
  • Others

By End User
  • Hospitals
  • Clinics
  • Others

By Region
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • Spain
  • Italy
  • UK
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • India
  • China
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT
  • Baxter International Inc.
  • Coloplast A/S
  • ConvaTec Inc.
  • Derma Sciences Inc.
  • Hollister Inc.
  • Johnson & Johnson
  • 3M Company
  • Medtronic Plc.
  • Mölnlycke Health Care
  • Smith & Nephew
Frequently Asked Questions about the Global Wound Management Devices Market

What is the estimated value of the Global Wound Management Devices Market?

The Global Wound Management Devices Market was estimated to be valued at $13396.8 million in 2018.

What is the growth rate of the Global Wound Management Devices Market?

The growth rate of the Global Wound Management Devices Market is 4.3%, with an estimated value of $18818.4 million by 2026.

What is the forecasted size of the Global Wound Management Devices Market?

The Global Wound Management Devices Market is estimated to be worth $18818.4 million by 2026.

Who are the key companies in the Global Wound Management Devices Market?

Key companies in the Global Wound Management Devices Market include Baxter International Inc., Coloplast A/S, ConvaTec Inc., Derma Sciences Inc., Hollister Inc., Johnson & Johnson, 3M Company, Medtronic Plc. and Smith & Nephew.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3M Company
  • Baxter International Inc.
  • Coloplast A/S
  • ConvaTec Inc.
  • Derma Sciences Inc.
  • Hollister Inc.

Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools and Models
Chapter 2: Executive Summary
2.1. Key Findings of the Study
2.2. CXO Perspective
Chapter 3: Market Overview
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Patent Analysis
3.3.1. By Region
3.3.2. By Applicant
3.4. Market Dynamics
3.4.1. Drivers
3.4.1.1. Rising Geriatric Population
3.4.1.2. Increase in Diabetic Population
3.4.1.3. Growing Number of Surgeries
3.4.2. Restraints
3.4.2.1. Higher Costs of Wound Care and Management
3.4.2.2. Reluctance in Adoption of Wound Management Therapies
3.4.3. Opportunities
3.4.3.1. Preference of Advanced Wound Care Devices
Chapter 4: Wound Management Devices Market, by Product
4.1. Overview
4.1.1. Market Size and Forecast
4.2. Therapy Devices
4.2.1. Key Market Trends, Growth Factors, and Opportunities
4.2.2. Market Size and Forecast, by Region
4.2.3. Market Analysis, by Country
4.3. Wound Closure Devices
4.3.1. Key Market Trends, Growth Factors, and Opportunities
4.3.2. Market Size and Forecast, by Region
4.3.3. Market Analysis, by Country
4.4. Other Devices
4.4.1. Key Market Trends, Growth Factors, and Opportunities
4.4.2. Market Size and Forecast, by Region
4.4.3. Market Analysis, by Country
Chapter 5: Wound Management Devices Market, by Application
5.1. Overview
5.1.1. Market Size and Forecast
5.2. Burns
5.2.1. Market Size and Forecast, by Region
5.2.2. Market Analysis, by Country
5.3. Diabetic Foot Ulcers
5.3.1. Market Size and Forecast, by Region
5.3.2. Market Analysis, by Country
5.4. Pressure Ulcers
5.4.1. Market Size and Forecast, by Region
5.4.2. Market Analysis, by Country
5.5. Surgical Wounds
5.5.1. Market Size and Forecast, by Region
5.5.2. Market Analysis, by Country
5.6. Others
5.6.1. Market Size and Forecast, by Region
5.6.2. Market Analysis, by Country
Chapter 6: Wound Management Devices Market, by End-user
6.1. Overview
6.1.1. Market Size and Forecast
6.2. Hospitals
6.2.1. Market Size and Forecast, by Region
6.2.2. Market Analysis, by Country
6.3. Clinics
6.3.1. Market Size and Forecast, by Region
6.3.2. Market Analysis, by Country
6.4. Others
6.4.1. Market Size and Forecast, by Region
6.4.2. Market Analysis, by Country
Chapter 7: Global Wound Management Devices Market, by Region
7.1. Overview
7.1.1. Market Size and Forecast
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, by Product
7.2.3. Market Size and Forecast, by Application
7.2.4. Market Size and Forecast, by End-user
7.2.5. Market Size and Forecast, by Country
7.2.5.1. U. S. Market Size and Forecast, by Product
7.2.5.2. U. S. Market Size and Forecast, by Application
7.2.5.3. U. S. Market Size and Forecast, by End-user
7.2.5.4. Canada Market Size and Forecast, by Product
7.2.5.5. Canada Market Size and Forecast, by Application
7.2.5.6. Canada Market Size and Forecast, by End-user
7.2.5.7. Mexico Market Size and Forecast, by Product
7.2.5.8. Mexico Market Size and Forecast, by Application
7.2.5.9. Mexico Market Size and Forecast, by End-user
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, by Product
7.3.3. Market Size and Forecast, by Application
7.3.4. Market Size and Forecast, by End-user
7.3.5. Market Size and Forecast, by Country
7.3.5.1. Germany Market Size and Forecast, by Product
7.3.5.2. Germany Market Size and Forecast, by Application
7.3.5.3. Germany Market Size and Forecast, by End-user
7.3.5.4. France Market Size and Forecast, by Product
7.3.5.5. France Market Size and Forecast, by Application
7.3.5.6. France Market Size and Forecast, by End-user
7.3.5.7. UK Market Size and Forecast, by Product
7.3.5.8. UK Market Size and Forecast, by Application
7.3.5.9. UK Market Size and Forecast, by End-user
7.3.5.10. Italy Market Size and Forecast, by Product
7.3.5.11. Italy Market Size and Forecast, by Application
7.3.5.12. Italy Market Size and Forecast, by End-user
7.3.5.13. Spain Market Size and Forecast, by Product
7.3.5.14. Spain Market Size and Forecast, by Application
7.3.5.15. Spain Market Size and Forecast, by End-user
7.3.5.16. Rest of Europe Market Size and Forecast, by Product
7.3.5.17. Rest of Europe Market Size and Forecast, by Application
7.3.5.18. Rest of Europe Market Size and Forecast, by End-user
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, by Product
7.4.3. Market Size and Forecast, by Application
7.4.4. Market Size and Forecast, by End-user
7.4.5. Market Size and Forecast, by Country
7.4.5.1. Japan Market Size and Forecast, by Product
7.4.5.2. Japan Market Size and Forecast, by Application
7.4.5.3. Japan Market Size and Forecast, by End-user
7.4.5.4. China Market Size and Forecast, by Product
7.4.5.5. China Market Size and Forecast, by Application
7.4.5.6. China Market Size and Forecast, by End-user
7.4.5.7. India Market Size and Forecast, by Product
7.4.5.8. India Market Size and Forecast, by Application
7.4.5.9. India Market Size and Forecast, by End-user
7.4.5.10. Australia Market Size and Forecast, by Product
7.4.5.11. Australia Market Size and Forecast, by Application
7.4.5.12. Australia Market Size and Forecast, by End-user
7.4.5.13. South Korea Market Size and Forecast, by Product
7.4.5.14. South Korea Market Size and Forecast, by Application
7.4.5.15. South Korea Market Size and Forecast, by End-user
7.4.5.16. Rest of Asia-Pacific Market Size and Forecast, by Product
7.4.5.17. Rest of Asia-Pacific Market Size and Forecast, by Application
7.4.5.18. Rest of Asia-Pacific Market Size and Forecast, by End-user
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, by Product
7.5.3. Market Size and Forecast, by Application
7.5.4. Market Size and Forecast, by End-user
7.5.5. Market Size and Forecast, by Country
7.5.5.1. Brazil Market Size and Forecast, by Product
7.5.5.2. Brazil Market Size and Forecast, by Application
7.5.5.3. Brazil Market Size and Forecast, by End-user
7.5.5.4. Saudi Market Size and Forecast, by Product
7.5.5.5. Saudi Market Size and Forecast, by Application
7.5.5.6. Saudi Market Size and Forecast, by End-user
7.5.5.7. South Africa Market Size and Forecast, by Product
7.5.5.8. South Africa Market Size and Forecast, by Application
7.5.5.9. South Africa Market Size and Forecast, by End-user
7.5.5.10. Rest of LAMEA Market Size and Forecast, by Product
7.5.5.11. Rest of LAMEA Market Size and Forecast, by Application
7.5.5.12. Rest of LAMEA Market Size and Forecast, by End-user
Chapter 8: Company Profiles
8.1. Baxter International Inc.
8.1.1. Company Overview
8.1.2. Company Snapshot
8.1.3. Operating Business Segments
8.1.4. Product Portfolio
8.1.5. Business Performance
8.2. Coloplast A/S
8.2.1. Company Overview
8.2.2. Company Snapshot
8.2.3. Operating Business Segments
8.2.4. Product Portfolio
8.2.5. Business Performance
8.2.6. Key Strategic Moves and Developments
8.3. Convatec Inc.
8.3.1. Company Overview
8.3.2. Company Snapshot
8.3.3. Operating Business Segments
8.3.4. Product Portfolio
8.3.5. Business Performance
8.4. Derma Sciences Inc.
8.4.1. Company Overview
8.4.2. Company Snapshot
8.4.3. Operating Business Segments
8.4.4. Product Portfolio
8.4.5. Business Performance
8.4.6. Key Strategic Moves and Developments
8.5. Hollister Inc.
8.5.1. Company Overview
8.5.2. Company Snapshot
8.5.3. Operating Business Segments
8.5.4. Product Portfolio
8.6. Johnson & Johnson
8.6.1. Company Overview
8.6.2. Company Snapshot
8.6.3. Operating Business Segments
8.6.4. Product Portfolio
8.6.5. Business Performance
8.6.1. Key Strategic Moves and Developments
8.7.3M Company
8.7.1. Company Overview
8.7.2. Company Snapshot
8.7.3. Operating Business Segments
8.7.4. Product Portfolio
8.7.5. Business Performance
8.7.6. Key Strategic Moves and Developments
8.8. Medtronic plc.
8.8.1. Company Overview
8.8.2. Company Snapshot
8.8.3. Operating Business Segments
8.8.4. Product Portfolio
8.8.5. Business Performance
8.9. Mölnlycke Health Care
8.9.1. Company Overview
8.9.2. Company Snapshot
8.9.3. Operating Business Segments
8.9.4. Product Portfolio
8.9.5. Business Performance
8.10. Smith & Nephew
8.10.1. Company Overview
8.10.2. Company Snapshot
8.10.3. Operating Business Segments
8.10.4. Product Portfolio
8.10.5. Business Performance
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3M Company
  • Baxter International Inc.
  • Coloplast A/S
  • ConvaTec Inc.
  • Derma Sciences Inc.
  • Hollister Inc.
According to the report titled 'Wound Management Devices Market by product, application, and end user: Opportunity Analysis and Industry Forecast, 2019-2026' the global wound management devices market size is expected to reach $18.8 billion by 2026, registering a CAGR of 4.3% from 2019 to 2026, in terms of value.Wounds are one of the most common afflictions that affect billions of people worldwide. Wounds can be classified into acute and chronic based on the severity. Acute wounds are often recovered by natural healing process whereas chronic wounds are hard to heal due to complications from cardiovascular diseases (CVD), obesity, diabetes, and other lifestyle diseases. Wound management is a comprehensive care plan that involves methods, measures, and interventions taken while healing patients with wounds. The basic principle of wound management involves 5 steps, namely, hemostasis, cleaning of the wound, analgesia, skin closure, and dressing, which is followed by precautionary advices from healthcare professionals. Wound management provides optimized conditions and environment to awound to restore and fasten its healing process. This includes maintaining stable temperature, optimal pH, bacterial balance, as well as selection of appropriate wound therapy. Chronic wound management requires intervention of healthcare professionals and appropriate inpatient care.

Increasing geriatric population across the globe, need for fast acting wound closure devices for prevention of blood loss during surgeries, and rise in number of people suffering from chronic wounds and ulcers due to various diseases such as diabetes and CVDs primarily drives market growth. In addition, technological advancements in wound healing procedures adopted by hospitals and clinics are further expected to boost market growth. However, higher cost of treatments involved in wound management techniques is anticipated to restrain the market globally. Moreover, lack of proper reimbursement policies in developing countries also hamper the growth of the wound management devices market. However, introduction of novel therapies for wound healing and growing number of therapy approvals such as negative pressure wound therapies and extra corporeal shock wave therapies, create newer opportunities for the growth of the market.

The wound management devices market is segmented on the basis of product, application, end user and region. On the basis of product, it is classified into therapy devices, wound closure devices, and others. The therapy devices segment was the highest contributor to the market, owing to the increasing usage of these devices in Negative pressure wound therapy (NPWT) systems, hyperbaric oxygen therapy systems, extra corporeal shock wave therapy systems, compression therapy systems, and electrical stimulation wound therapy systems. On the basis of application, the wound management devices market is divided into burns, diabetic foot ulcers, pressure ulcers, surgical wounds and others. The burns segment was the highest contributor to the market, since these injuries are common and are caused by flames, steams, or agents such as chemicals, tar, and electricity.On the basis of, it is segmented into hospitals, clinics, home care settings and others. The hospitals segment dominated the market in 2018 and is anticipated to maintain its dominance throughout the forecast period. This is attributed to the preference among individuals for hospitals compared to clinics and other end users. Region wise, the market is further analyzed across North America, Europe, Asia-Pacific and LAMEA. North America occupied largest share in the wound management devices market in 2018, and is expected to continue its dominance during the forecast period, owing to increase in incidences of chronic wounds amongst the population. Moreover, growing geriatric population along with chronic diseases and rise in awareness regarding wound management devices through medical tourism programs in the region are anticipated to propel market growth in this region.Asia-Pacific is anticipated to grow at the highest growth rate during the forecast period due to large pool of population with unmet medical needs and changes in lifestyle. The growth is mainly attributed to the attempts of reducing surgical costs by minimizing the duration of hospital stays. Furthermore, developing countries such as China and India are expected to fuel the wound management devices market growth, owing to increasing incidences of diseases such as obesity and diabetes.

Key Findings of the Study:

North America occupied 44.88%the global wound management devices market share in 2018.
By application, diabetic foot ulcers segment is anticipated to grow with the highest CAGR throughout the forecast period.
The hospitals segment is anticipated to grow at the 4.2% during the analysis period.

Comprehensive competitive analysis and profiles of major market players such as Baxter International Inc., Coloplast A/S, ConvaTec Inc., Derma Sciences Inc., Hollister Inc., Johnson & Johnson, 3M Company, Medtronic Plc., Mölnlycke Health Care, and Smith & Nephew have been provided in this report.
Note: Product cover images may vary from those shown
  • Baxter International Inc.
  • Coloplast A/S
  • ConvaTec Inc.
  • Derma Sciences Inc.
  • Hollister Inc.
  • Johnson & Johnson
  • 3M Company
  • Medtronic Plc.
  • Mölnlycke Health Care
  • Smith & Nephew
Note: Product cover images may vary from those shown

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...